Displaying results 25 - 36 of 72
Public Health and Advocacy
EASL Policy Statement on Liver Cancer Screening

EASL Policy Statement on Liver Cancer Screening

PDF
View
Public Health and Advocacy
EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - EN

EASL Policy Statement on Hepatitis C Elimination - EN

PDF
View
Public Health and Advocacy
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View
Public Health and Advocacy
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Public Health and Advocacy
EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues
View
Liver Tumours
EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio
View
Metabolism, Alcohol & Toxicity

Introduction and presentation of the NAFLD patient guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

The user perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the models of care

Webcasts
View